Annual Debt To Equity
-1.78
-2.99-247.11%
31 December 2023
Summary:
BioXcel Therapeutics annual debt to equity ratio is currently -1.78, with the most recent change of -2.99 (-247.11%) on 31 December 2023. During the last 3 years, it has fallen by -1.79 (-17900.00%). BTAI annual debt to equity is now -132.25% below its all-time high of 5.52, reached on 01 July 2016.BTAI Debt To Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Debt To Equity
-1.22
+0.17+12.23%
30 September 2024
Summary:
BioXcel Therapeutics quarterly debt to equity ratio is currently -1.22, with the most recent change of +0.17 (+12.23%) on 30 September 2024. Over the past year, it has increased by +1.22 (+50.00%). BTAI quarterly debt to equity is now -107.38% below its all-time high of 16.52, reached on 30 June 2023.BTAI Quarterly Debt To Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BTAI Debt To Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -247.1% | +50.0% |
| 3 y3 years | -10000.0% | -10000.0% |
| 5 y5 years | -100.0% | -4166.7% |
BTAI Debt To Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -247.1% | at low | -107.4% | +50.0% |
| 5 y | 5 years | -247.1% | at low | -107.4% | +50.0% |
| alltime | all time | -132.3% | +73.8% | -107.4% | +50.0% |
BioXcel Therapeutics Debt To Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -1.22(-12.2%) |
| June 2024 | - | -1.39(-0.7%) |
| Mar 2024 | - | -1.40(-21.3%) |
| Dec 2023 | -1.78(-247.1%) | -1.78(-27.0%) |
| Sept 2023 | - | -2.44(-114.8%) |
| June 2023 | - | 16.52(+822.9%) |
| Mar 2023 | - | 1.79(+47.9%) |
| Dec 2022 | 1.21(>+9900.0%) | 1.21(+68.1%) |
| Sept 2022 | - | 0.72(+89.5%) |
| June 2022 | - | 0.38(+3700.0%) |
| Mar 2022 | - | 0.01(>+9900.0%) |
| Dec 2021 | 0.00(-100.0%) | 0.00(-100.0%) |
| Sept 2021 | - | 0.01(>+9900.0%) |
| June 2021 | - | 0.00(-100.0%) |
| Mar 2021 | - | 0.01(0.0%) |
| Dec 2020 | 0.01 | 0.01(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2020 | - | 0.01(-50.0%) |
| June 2020 | - | 0.02(+100.0%) |
| Mar 2020 | - | 0.01(-75.0%) |
| Dec 2019 | 0.04(>+9900.0%) | 0.04(+33.3%) |
| Sept 2019 | - | 0.03(-25.0%) |
| June 2019 | - | 0.04(0.0%) |
| Mar 2019 | - | 0.04(>+9900.0%) |
| Dec 2018 | 0.00(-100.0%) | 0.00(0.0%) |
| Sept 2018 | - | 0.00(0.0%) |
| June 2018 | - | 0.00(0.0%) |
| Mar 2018 | - | 0.00(-100.0%) |
| Dec 2017 | -0.38(<-9900.0%) | -0.38 |
| Dec 2016 | 0.00(-100.0%) | - |
| July 2016 | 5.52(+195.2%) | - |
| July 2015 | 1.87(-127.5%) | - |
| July 2014 | -6.79 | - |
FAQ
- What is BioXcel Therapeutics annual debt to equity ratio?
- What is the all time high annual debt to equity for BioXcel Therapeutics?
- What is BioXcel Therapeutics annual debt to equity year-on-year change?
- What is BioXcel Therapeutics quarterly debt to equity ratio?
- What is the all time high quarterly debt to equity for BioXcel Therapeutics?
- What is BioXcel Therapeutics quarterly debt to equity year-on-year change?
What is BioXcel Therapeutics annual debt to equity ratio?
The current annual debt to equity of BTAI is -1.78
What is the all time high annual debt to equity for BioXcel Therapeutics?
BioXcel Therapeutics all-time high annual debt to equity ratio is 5.52
What is BioXcel Therapeutics annual debt to equity year-on-year change?
Over the past year, BTAI annual debt to equity ratio has changed by -2.99 (-247.11%)
What is BioXcel Therapeutics quarterly debt to equity ratio?
The current quarterly debt to equity of BTAI is -1.22
What is the all time high quarterly debt to equity for BioXcel Therapeutics?
BioXcel Therapeutics all-time high quarterly debt to equity ratio is 16.52
What is BioXcel Therapeutics quarterly debt to equity year-on-year change?
Over the past year, BTAI quarterly debt to equity ratio has changed by +1.22 (+50.00%)